Waters Earns Top Score in Human Rights Campaign Foundation's 2023-2024 Corporate Equality IndexPRNewsWire • 12/05/23
Waters Corporation to Present at the Evercore ISI HealthCONx 2023 Health Care ConferencePRNewsWire • 11/16/23
WATERS 2023 ESG REPORT HIGHLIGHTS CONTINUED PROGRESS TOWARDS SUSTAINABILITY COMMITMENTSPRNewsWire • 11/16/23
Compared to Estimates, Waters (WAT) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 11/08/23
Curious about Waters (WAT) Q3 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 11/06/23
Among the S&P 500, these 20 companies have made the best use of investors' moneyMarket Watch • 10/25/23
Waters Accelerates Oligonucleotide Bioanalysis with the Launch of OligoWorks™ SPE Workflow and KitsPRNewsWire • 10/19/23
Waters Corporation: Buybacks Ceased, Incremental Returns Languishing (Rating Downgrade)Seeking Alpha • 09/27/23
Waters Has Made Progress In Repositioning The Business, And The Valuation Is Much More Accommodating NowSeeking Alpha • 09/27/23
Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological TherapiesPRNewsWire • 09/20/23
Waters Corporation (WAT) Bank of America Global Healthcare Conference 2023 (Transcript)Seeking Alpha • 09/15/23
Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture MediaPRNewsWire • 09/12/23
Waters Corporation to Present at the Bank of America Global Healthcare Conference 2023PRNewsWire • 08/30/23
Waters (WAT) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 08/02/23